-
Signal Detection and Network Pharmacology Analysis of Paronychia Associated With eGFR Inhibitors
Sep 9, 2025, 16:22 PM -
The Key Role of Social Participation in Health Technology Assessment: Experiences From South American Countries
Sep 9, 2025, 16:22 PM -
The Overlooked Need for Modeling Beyond Reimbursement to Support Therapy Uptake: Case Study of Botulinum Toxin for Spasticity Treatment
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Noninvasive Tests Strategies for Metabolic Dysfunction-Associated Steatohepatitis (MASH) Diagnosis in Japan
Sep 9, 2025, 16:22 PM -
Economic and Epidemiological Burden of Type 1 Diabetes In France
Sep 9, 2025, 16:22 PM -
Humanistic and Financial Burden Experienced by Nonprofessional Care Partners of Patients With Mild Cognitive Impairment and Dementia Due to Alzheimer’s Disease: Results From a Real-World Survey in Spain
Sep 9, 2025, 16:22 PM -
Cost-Consequence of Incorporating Single-Operator Direct Visualization Cholangioscopy in the Diagnosis of Indeterminate Biliary Strictures in Saudi Arabia
Sep 9, 2025, 16:22 PM -
Delphi Panel for Standardizing Outcome Measures in Radical Prostatectomy Surgical Care Pathway
Sep 9, 2025, 16:22 PM -
Life-Years Lost Due to Regulatory and Reimbursement Delays: A Study of Oncology Drugs Across England, Scotland, and France, 2022-2024
Sep 9, 2025, 16:22 PM -
Multiple Myeloma Caregiver Costs and Disabilities Data for Economic Modeling and HTA Submissions
Sep 9, 2025, 16:22 PM -
Burden of Illness Among Patients With Transfusion Dependent Beta-Thalassemia in Spain: A Registry-Based Study
Sep 9, 2025, 16:22 PM -
Divergent Biologic Price Archetypes: Year-on-Year List Price Evolution Pre- and Post-Biosimilar Entry in the US, Europe, and Japan
Sep 9, 2025, 16:22 PM -
Differential Responsiveness and Minimally Important Difference of EQ-5D: Truth or Artifact?
Sep 9, 2025, 16:22 PM -
Scientific Outcome of ISPOR Conferences: An Analysis of 67,055 Abstracts Presented at 54 ISPOR Conferences Between 2002-2024
Sep 9, 2025, 16:22 PM -
Why Current HTA Frameworks Fall Short for Anti-Cancer Combination Therapies: Toward Equitable Value Attribution and Policy Reform
Sep 9, 2025, 16:22 PM -
Modeling the Healthcare Burden of Oral Corticosteroid Use in Mexico
Sep 9, 2025, 16:22 PM -
What Are the Biggest Value Drivers? A Comparison of the Relative Impacts of Six Novel Value Elements on Value Estimates Across Twelve Treatments Through Generalized Cost-Effectiveness Analyses
Sep 9, 2025, 16:22 PM -
Matching-Adjusted Indirect Comparison Between Garadacimab and Donidalorsen for Long-Term Prophylaxis in Hereditary Angioedema
Sep 9, 2025, 16:22 PM -
Health Equity in Economic Analyses of Person-Centered Care: A Systematic Review
Sep 9, 2025, 16:22 PM -
Relevance of Quality Indicators for Supporting Patients’ Choice of Hospitals: An Online Survey
Sep 9, 2025, 16:22 PM
